Trial Outcomes & Findings for Clinical Assessment of a Daily Wear Monthly Replacement Silicone Hydrogel Toric Contact Lens (NCT NCT05211739)

NCT ID: NCT05211739

Last Updated: 2023-06-27

Results Overview

Visual acuity (VA) was collected for each eye individually with study lenses in place using a letter chart. VA was measured in logarithm minimum angle of resolution (logMAR). A logMAR value of 0 equates to 20/20 Snellen visual acuity (normal distance eyesight), with a lower logMAR value indicating better visual acuity. No inferences were pre-specified for the primary effectiveness endpoint; therefore, no hypothesis testing was performed.

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

76 participants

Primary outcome timeframe

Day 1 and Day 30, each wear period (approximately 30 days)

Results posted on

2023-06-27

Participant Flow

Participants were recruited from 7 investigative sites located in the United States.

Of the 76 subjects enrolled in the study (i.e., signed informed consent), 2 subjects were exited prior to randomization as screen failures, and 1 randomized subject withdrew prior to exposure to the study lenses. This reporting group includes all randomized subjects/eyes (74/148).

Unit of analysis: eyes

Participant milestones

Participant milestones
Measure
LID205255 Toric, Then Biofinity Toric
Lehfilcon A toric contact lenses worn first, with comfilcon A toric contact lenses worn second, as randomized. Each product was worn bilaterally (in both eyes) during waking hours for at least 5 days per week, with up to 10-12 hours wear time per day over a 30-day period. CLEAR CARE was used for nightly contact lens cleaning and disinfection.
Biofinity Toric, Then LID205255 Toric
Comfilcon A toric contact lenses worn first, with lehfilcon A toric contact lenses worn second, as randomized. Each product was worn bilaterally (in both eyes) during waking hours for at least 5 days per week, with up to 10-12 hours wear time per day over a 30-day period. CLEAR CARE was used for nightly contact lens cleaning and disinfection.
First Wear Period (Approx 30 Days)
STARTED
36 72
38 76
First Wear Period (Approx 30 Days)
Exposed to Study Lenses
35 70
38 76
First Wear Period (Approx 30 Days)
COMPLETED
35 70
36 72
First Wear Period (Approx 30 Days)
NOT COMPLETED
1 2
2 4
Second Wear Period (Approx 30 Days)
STARTED
35 70
36 72
Second Wear Period (Approx 30 Days)
COMPLETED
34 68
36 72
Second Wear Period (Approx 30 Days)
NOT COMPLETED
1 2
0 0

Reasons for withdrawal

Reasons for withdrawal
Measure
LID205255 Toric, Then Biofinity Toric
Lehfilcon A toric contact lenses worn first, with comfilcon A toric contact lenses worn second, as randomized. Each product was worn bilaterally (in both eyes) during waking hours for at least 5 days per week, with up to 10-12 hours wear time per day over a 30-day period. CLEAR CARE was used for nightly contact lens cleaning and disinfection.
Biofinity Toric, Then LID205255 Toric
Comfilcon A toric contact lenses worn first, with lehfilcon A toric contact lenses worn second, as randomized. Each product was worn bilaterally (in both eyes) during waking hours for at least 5 days per week, with up to 10-12 hours wear time per day over a 30-day period. CLEAR CARE was used for nightly contact lens cleaning and disinfection.
First Wear Period (Approx 30 Days)
Adverse Event
0
1
First Wear Period (Approx 30 Days)
Withdrawal by Subject Prior to Exposure to the Study Lenses
1
0
First Wear Period (Approx 30 Days)
Withdrawal by Subject
0
1
Second Wear Period (Approx 30 Days)
Adverse Event
1
0

Baseline Characteristics

Clinical Assessment of a Daily Wear Monthly Replacement Silicone Hydrogel Toric Contact Lens

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
LID205255 Toric, Then Biofinity Toric
n=36 Participants
Lehfilcon A toric contact lenses worn first, with comfilcon A toric contact lenses worn second, as randomized. Each product was worn bilaterally (in both eyes) during waking hours for at least 5 days per week, with up to 10-12 hours wear time per day over a 30-day period. CLEAR CARE was used for nightly contact lens cleaning and disinfection.
Biofinity Toric, Then LID205255 Toric
n=38 Participants
Comfilcon A toric contact lenses worn first, with lehfilcon A toric contact lenses worn second, as randomized. Each product was worn bilaterally (in both eyes) during waking hours for at least 5 days per week, with up to 10-12 hours wear time per day over a 30-day period. CLEAR CARE was used for nightly contact lens cleaning and disinfection.
Total
n=74 Participants
Total of all reporting groups
Age, Continuous
32.9 year
STANDARD_DEVIATION 8.3 • n=93 Participants
35.8 year
STANDARD_DEVIATION 10.2 • n=4 Participants
34.4 year
STANDARD_DEVIATION 9.4 • n=27 Participants
Sex: Female, Male
Female
26 Participants
n=93 Participants
25 Participants
n=4 Participants
51 Participants
n=27 Participants
Sex: Female, Male
Male
10 Participants
n=93 Participants
13 Participants
n=4 Participants
23 Participants
n=27 Participants
Ethnicity (NIH/OMB)
Hispanic or Latino
3 Participants
n=93 Participants
6 Participants
n=4 Participants
9 Participants
n=27 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
33 Participants
n=93 Participants
32 Participants
n=4 Participants
65 Participants
n=27 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
0 Participants
n=93 Participants
0 Participants
n=4 Participants
0 Participants
n=27 Participants
Race/Ethnicity, Customized
White
31 Participants
n=93 Participants
32 Participants
n=4 Participants
63 Participants
n=27 Participants
Race/Ethnicity, Customized
Black or African American
2 Participants
n=93 Participants
3 Participants
n=4 Participants
5 Participants
n=27 Participants
Race/Ethnicity, Customized
Asian
3 Participants
n=93 Participants
2 Participants
n=4 Participants
5 Participants
n=27 Participants
Race/Ethnicity, Customized
Missing
0 Participants
n=93 Participants
1 Participants
n=4 Participants
1 Participants
n=27 Participants

PRIMARY outcome

Timeframe: Day 1 and Day 30, each wear period (approximately 30 days)

Population: All subjects exposed to any study lenses evaluated in this study, as randomized, with non-missing data at the respective visit.

Visual acuity (VA) was collected for each eye individually with study lenses in place using a letter chart. VA was measured in logarithm minimum angle of resolution (logMAR). A logMAR value of 0 equates to 20/20 Snellen visual acuity (normal distance eyesight), with a lower logMAR value indicating better visual acuity. No inferences were pre-specified for the primary effectiveness endpoint; therefore, no hypothesis testing was performed.

Outcome measures

Outcome measures
Measure
LID205255 Toric
n=142 eyes
Lehfilcon A toric contact lenses worn first or second, as randomized, in both eyes during waking hours for at least 5 days per week, with up to 10-12 hours wear time per day over a 30-day period. CLEAR CARE was used for nightly contact lens cleaning and disinfection.
Biofinity Toric
n=146 eyes
Comfilcon A toric contact lenses worn first or second, as randomized, in both eyes during waking hours for at least 5 days per week, with up to 10-12 hours wear time per day over a 30-day period. CLEAR CARE was used for nightly contact lens cleaning and disinfection.
Distance Visual Acuity (VA) With Study Lenses
Day 1
-0.06 logMAR
Standard Deviation 0.09
-0.07 logMAR
Standard Deviation 0.09
Distance Visual Acuity (VA) With Study Lenses
Day 30
-0.08 logMAR
Standard Deviation 0.09
-0.06 logMAR
Standard Deviation 0.08

Adverse Events

Pretreatment

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

LID205255 Toric Ocular

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

LID205255 Toric Nonocular

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Biofinity Toric Ocular

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Biofinity Toric Nonocular

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Clinical Project Lead, CRD Vision Care

Alcon Research, LLC

Phone: 1-888-451-3937

Results disclosure agreements

  • Principal investigator is a sponsor employee Sponsor reserves the right of prior review of any publication or presentation of information related to the study.
  • Publication restrictions are in place

Restriction type: OTHER